Heena Sharma Blog

  Ganga Ram hospital Chairperson Dr DS Rana on Tuesday said that Remdesivir is also being considered to be dropped from COVID-19 treatment soon as there is no evidence of its effectiveness in treating COVID-19 patients. This move comes after, the use of convalescent plasma has been dropped from the recommended treatment protocols for COVID -19, according to advisory from the Indian Council of Medical Research (ICMR). While talking to ANI, Ganga Ram hospital Chairperson Dr DS Rana said, "In plasma therapy, we give a pre-forwarded antibody to someone who has been infected before, so that the antibody can fight with the virus. Antibodies usually form when the coronavirus attacks. We have seen in the last one year that giving plasma does not make any difference in the condition of the patient and other people. Also, it is not easily available. Plasma therapy was started on a scientific basis and has been discontinued on the basis of evidence." Read More

  Amid the record rise in COVID-19 cases in India, medical assistance is continuing to pour in from countries around the world, including the US, Singapore and Australia. The Ministry of External Affairs (MEA) informed that 81000 vials of Remdesivir from the US arrived early on Wednesday morning in Mumbai. "Further elevating the India and United States Strategic Partnership. Appreciate the shipment of over 81,000 vials of Remdesivir from the US that arrived early this morning in Mumbai (India)," MEA spokesperson Arindam Bagchi said in a tweet. Besides the US, 3,650 oxygen cylinders and 8 ISO tanks are on their way from Singapore. "3,650 oxygen cylinders, 8 ISO tanks and much more-tremendous effort by Indian community and well-wishers of India to mobilise COVID-relief assistance from Singapore," High Commission in Singapore tweeted. Read More